About Epocal
Epocal is a company based in Ottawa (Canada) founded in 2001 was acquired by Siemens in July 2017.. Epocal has raised $40.51 million across 6 funding rounds from investors including Siemens, Highland Capital and Genesys Capital. Epocal operates in a competitive market with competitors including Daxor, Hemcheck, Cellmic, Essenlix and Chipcare, among others.
- Headquarter Ottawa, Canada
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Epocal
Epocal has successfully raised a total of $40.51M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $31 million completed in April 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series C — $31.0M
-
First Round
First Round
(01 Jun 2001)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2007 | Amount | Series C - Epocal | Valuation |
investors |
|
| Jan, 2006 | Amount | Debt – Venture - Epocal | Valuation |
investors |
|
| Apr, 2005 | Amount | Series B - Epocal | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Epocal
Epocal has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Siemens, Highland Capital and Genesys Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage life sciences companies are supported through venture capital investments.
|
Founded Year | Domain | Location | |
|
Tech & Life-Sciences focused Growth stage Venture Debt Firm investing in North America
|
Founded Year | Domain | Location | |
|
Investment management services are offered by Highland Capital.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Epocal
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Epocal
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Epocal Comparisons
Competitors of Epocal
Epocal operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Daxor, Hemcheck, Cellmic, Essenlix and Chipcare, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Blood volume analyzers are developed by Daxor for diagnostic applications.
|
|
| domain | founded_year | HQ Location |
Devices for detecting hemolyzed blood samples are provided by Hemcheck.
|
|
| domain | founded_year | HQ Location |
Rapid test readers are developed for chromatographic and fluorescent assays.
|
|
| domain | founded_year | HQ Location |
Mobile health self-test platform is provided using nanotechnology and AI.
|
|
| domain | founded_year | HQ Location |
Develops a hand-held blood test device from a single drop of blood.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Epocal
When was Epocal founded?
Epocal was founded in 2001.
Where is Epocal located?
Epocal is headquartered in Ottawa, Canada. It is registered at Ottawa, Ontario, Canada.
Is Epocal a funded company?
Epocal is a funded company, having raised a total of $40.51M across 6 funding rounds to date. The company's 1st funding round was a Series B of $5.35M, raised on Jun 01, 2001.
What does Epocal do?
Epocal researches and develops biochips and solid-state diagnostic devices. Epocal is implementing an entire blood diagnostic system in FlexCard technology, a card format similar to the smart card used in conventional check and telephone cards. Epocal manufactures cards at ultra low cost, leveraging already existing high volume low cost production technologies for smart cards. The proprietary FlexCard technology, comprising biosensors and integral fluidics on flex circuit modules in a credit card-sized housing. The companys new enterprise point-of-care blood diagnostic system, the Epoc comprising diagnostic test cards and wireless card readers is intended to be used in all low volume, distributed testing applications, where high sensitivity and lab quality accuracy is required: in hospitals at the bedside, in physicians offices and in patients homes.
Who are the top competitors of Epocal?
Epocal's top competitors include Daxor, Pathshodh Healthcare and Cellmic.
Who are Epocal's investors?
Epocal has 4 investors. Key investors include Siemens, Highland Capital, Genesys Capital, and MMV Financial.